Citi Invests in ChartIQ's Finsemble

Citi is the first Series B strategic investor for ChartIQ's desktop integration platform.

US dollar

Citi, the bank itself and not its Citi Ventures arm, has stepped in as the first strategic investor in ChartIQ’s Finsemble, one of the entrants in the growing desktop integration space. The financial terms of the deal are undisclosed, but the investment follows as an add-on strategic investment just as the bulk of the Charlottesville-based firm’s Series B funding closed.

ChartIQ CEO Dan Schleifer said the company knows Citi well, and the decision to partner with the company was a natural one

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

Broadridge CEO: ‘We intend to be a leader in AI’

In 2023, Broadridge became one of the first capital markets-focused companies to roll out a GPT-powered tool. Now it is looking across use cases and foundational models to determine where to plant its flag next.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here